Tarlatamab's role in SCLC
Tarlatamab's role in SCLC
WCLC 2026: Lung cancer research highlights
Safeguarding the right to work for people with advanced breast cancer (ABC) and their caregivers: A global snapshot of legislati
Equitable precision oncology in Africa
Harnessing AI and data to predict, personalise and transform cancer care
Izalontamab brenitecan shows promising activity in previously treated EGFR mutated NSCLC
Sequencing breast cancer scale-up in LMICs: Using service assessment to shape national priorities in Ethiopia
Political prioritisation as a driver of vaccine introduction: Evidence from Nigeria’s HPV rollout
Cost of standard-of-care cancer treatment and financing gaps under AB PM-JAY in India
Choice of wording may influence global acceptance of adapted childhood cancer treatment guidelines
Multilevel factors shaping blinatumomab delivery across diverse LMICs
Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC